Google News – Oncology External News
Biotechnology Articles
Google News – Biotech Funding External News
Italian biotech gains momentum as VC funding, tech transfer environment improve - BioSpace
Google News – Oncology External News
AstraZeneca ends phase 3 lung cancer trial after bispecific falls short versus Keytruda - Fierce Biotech
Google News – FDA (biotech/pharma) External News
FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vax - BioPharma Dive
Google News – EMA (biotech/pharma) External News
EMA Begins Review of Pfizer-Valneva Lyme Disease Vaccine - Contract Pharma
Google News – FDA (biotech/pharma) External News
Capricor soars on plan to amend DMD filing after adcomm setback - Fierce Biotech
Google News – EMA (biotech/pharma) External News
Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision - Fierce Pharma
Google News – EMA (biotech/pharma) External News
EMA takes Pfizer and Valneva Lyme disease vaccine into review - The Pharma Letter
Google News – Biotech Funding External News
Biotech VCs have become like bankers and we might all pay the price - Financial Times
Google News – Oncology External News
PDS halts work on phase 3 cancer therapy to focus on colorectal contender - Fierce Biotech
Google News – Oncology External News
Seattle biotech InduPro raises $77 million to advance cancer treatment pipeline - The Business Journals
Google News – FDA (biotech/pharma) External News
Zealand sells its rights to Takeda’s blood cancer drug for $100M ahead of FDA approval decision - Fierce Biotech
Google News – Biotech Funding External News
Biotech initiatives pick up as more regions race to become hubs - Pharma Voice
Google News – Biotech Funding External News
The 50 best-funded biotech companies of 2026 - drugdiscoverytrends.com
Google News – Oncology External News